
Persistence of Antibodies Induced by Measles-Mumps-Rubella Vaccine in Children in India
Author(s) -
Sidram Raut,
Prasad S. Kulkarni,
Mrudula Phadke,
Suresh Jadhav,
Subhash V. Kapre,
Rajeev Dhere,
Sanjay P. Dhorje,
S. R. Godse
Publication year - 2007
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00246-07
Subject(s) - measles , rubella , mmr vaccine , virology , vaccination , antibody , medicine , measles mumps rubella vaccine , immunology , rubella vaccine , immunity , mumps vaccine , immunization , immune system
Antibody levels in 41 Indian girls were measured 6 years after measles-mumps-rubella (MMR) vaccination. Rates of seropositivity were 88% (measles antibodies), 95% (mumps antibodies), and 100% (rubella antibodies). The MMR vaccine induces long-term immunity in a majority of vaccinees; however, due to the observation of some seronegative vaccinees, the policy of administering a second dose of the MMR vaccine seems appropriate.